Trademark: VALO OPAL COMPUTATIONAL PLATFORM 2207074
Word
VALO OPAL COMPUTATIONAL PLATFORM
ID
2207074
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
15 March 2021
Registration Date
15 March 2021
Renewal Date
15 March 2031
Owner(s)
Service
King & Wood Mallesons
Goods and Services:
Class 9:
Software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement.
Software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement.
Class 42:
Research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; scientific consulting in the fields of drug discovery and development, clinical trial management and patient engagement.
Research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; scientific consulting in the fields of drug discovery and development, clinical trial management and patient engagement.